| Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies BD Lehmann, JA Bauer, X Chen, ME Sanders, AB Chakravarthy, Y Shyr, ... The Journal of clinical investigation 121 (7), 2750, 2011 | 5744 | 2011 |
| Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection BD Lehmann, B Jovanović, XI Chen, MV Estrada, KN Johnson, Y Shyr, ... PloS one 11 (6), e0157368, 2016 | 1265 | 2016 |
| Random forests for genomic data analysis X Chen, H Ishwaran Genomics, 2012 | 871 | 2012 |
| Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 449 | 2020 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 439 | 2019 |
| Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 385 | 2021 |
| A rectal cancer organoid platform to study individual responses to chemoradiation K Ganesh, C Wu, KP O’Rourke, BC Szeglin, Y Zheng, CEG Sauvé, ... Nature medicine 25 (10), 1607-1614, 2019 | 363 | 2019 |
| New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx M Mounir, M Lucchetta, TC Silva, C Olsen, G Bontempi, X Chen, ... PLoS computational biology 15 (3), e1006701, 2019 | 353 | 2019 |
| PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors BD Lehmann, JA Bauer, JM Schafer, CS Pendleton, L Tang, KC Johnson, ... Breast Cancer Research 16, 1-14, 2014 | 353 | 2014 |
| Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 320 | 2020 |
| Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ... Cell 183 (5), 1436-1456. e31, 2020 | 306 | 2020 |
| Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer CM Lovly, NT McDonald, H Chen, S Ortiz-Cuaran, LC Heukamp, Y Yan, ... Nature medicine 20 (9), 1027-1034, 2014 | 293 | 2014 |
| TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer X Chen, J Li, WH Gray, BD Lehmann, JA Bauer, Y Shyr, JA Pietenpol Cancer Informatics 11, 147, 2012 | 268 | 2012 |
| Proteogenomic characterization of pancreatic ductal adenocarcinoma L Cao, C Huang, DC Zhou, Y Hu, TM Lih, SR Savage, K Krug, DJ Clark, ... Cell 184 (19), 5031-5052. e26, 2021 | 267 | 2021 |
| Gene set analysis of genome-wide association studies: methodological issues and perspectives L Wang, P Jia, RD Wolfinger, X Chen, Z Zhao Genomics 98 (1), 1-8, 2011 | 237 | 2011 |
| Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 213 | 2021 |
| Random survival forests for high‐dimensional data H Ishwaran, UB Kogalur, X Chen, AJ Minn Statistical Analysis and Data Mining 4 (1), 115-132, 2011 | 209 | 2011 |
| Integrated proteogenomic characterization across major histological types of pediatric brain cancer F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury, D Rykunov, A Krek, ... Cell 183 (7), 1962-1985. e31, 2020 | 200 | 2020 |
| Smad4-Mediated Signaling Inhibits Intestinal Neoplasia by Inhibiting Expression of β-Catenin TJ Freeman, JJ Smith, X Chen, MK Washington, JT Roland, AL Means, ... Gastroenterology, 2011 | 193 | 2011 |
| Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer KD Yu, R Zhu, M Zhan, AA Rodriguez, W Yang, S Wong, A Makris, ... Clinical cancer research 19 (10), 2723-2733, 2013 | 192 | 2013 |
Brian D. Lehmann, PhDResearch Associate Professor of Medicine, Vanderbilt Universityvumc.org의 이메일 확인됨
